Intellectual Property Policy

A Study of Issues Relating to the Patentability of Biotechnological Subject Matter: Table of Contents

[ Next ]


Dr. John R. Rudolph: Gowling, Strathy & Henderson

Table of Contents


  • DISCLAIMER
  • EXECUTIVE SUMMARY
  • Chapter 1: INTRODUCTION and OVERVIEW
  • Chapter 2: SUBJECT MATTER OF BIOTECHNOLOGY
    1. Bio-matter Itself
      • Non-living Bio-matter Living Bio-matter
    2. Methods and Processes of Making Products of Biotechnology
    3. Methods of Use or Uses
  • Chapter 3: ON THE NATURE OF INVENTION
    1. Introduction
    2. Invention
    3. Invention as a Result
    4. Invention as a Process
    5. Avenues to Invention
    6. Creation and Invention
    7. Discovery and Invention
    8. What Does "Invention" Mean - A Synthesis
  • Chapter 4: PATENTABLE INVENTION
    • The Quid Pro Quo of a Patent
      • Statutory Invention
    • DOES BIOTECHNOLOGY FIT?: Proper Subject-matter
      1. Methods of Medical Treatment
      2. Human Beings
      3. Enumerated Categories of Statutory Invention
        • Manufacture and Composition of Matter
      4. Scope of Patents for Higher Life Forms
        • Essence of Invention
        • Mere Aggregation?
        • Sound Prediction?
        • The Problem of Progeny
        • Infringement and the Doctrine of Equivalents
    • NEW, USEFUL and UNOBVIOUS - DOES BIOTECHNOLOGY FIT?: Specific Issues of Patentability
      1. Utility
      2. Novelty
        • Availability to the Public
        • Product of Nature Doctrine
        • Standard of Novelty Assessment in CIPO
      3. Non-obviousness
        • The Worth A Try Doctrine
        • Desideratum Inventions
        • Examiners Expertise - The Technician Skilled in the Art
  • Chapter 5: CONCLUSIONS and DIRECTIONS
    1. Introduction
    2. Summary
    3. The Patentability of Higher Life forms
      • "Manufacture or Composition of Matter"
      • Human Beings are Not Patentable
      • Problems with Progeny
    4. Novelty and Invention in Biotechnology
      • Amending the Act and Dilution of the Standard of Novelty
      • The Products of Biotechnology Act
    5. Non-obviousness in Biotechnology
    6. Conclusions
  • APPENDIX "A"
  • BIBLIOGRAPHY
  • FOOTNOTES

[ Next ]